Dysregulated Expression of MiR-19b, MiR-25, MiR-17, WT1, and CEBPA in Patients with Acute Myeloid Leukemia and Association with Graft versus Host Disease after Hematopoietic Stem Cell Transplantation

Objectives  Acute myeloid leukemia (AML) is a blood malignancy characterized by the proliferation of aberrant cells in the bone marrow and blood that interfere with normal blood cells. We have investigated whether changes in the level of micro-ribonucleic acid (miR)-19b, miR-17, and miR-25, Wilms�...

Descripción completa

Detalles Bibliográficos
Autores principales: Saadi, Mahdiyar Iravani, Tahmasebijaroubi, Fatemeh, Noshadi, Esmat, Rahimikian, Raha, Karimi, Zahed, Owjfard, Maryam, Niknam, Ahmad, Abdolyousefi, Ehsan Nabi, Salek, Sanaz, Tabrizi, Reza, Jamali, Elham
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Thieme Medical and Scientific Publishers Pvt. Ltd. 2022
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9902101/
https://www.ncbi.nlm.nih.gov/pubmed/36756106
http://dx.doi.org/10.1055/s-0042-1742593

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9902101/
https://www.ncbi.nlm.nih.gov/pubmed/36756106
http://dx.doi.org/10.1055/s-0042-1742593

Ejemplares similares